Trade JnJ ^JNJ

Johnson & Johnson (JNJ) Taps Sail Biomedicines in Bid for CAR-T Edge Over Bristol Myers Squibb

Forget Nvidia. Johnson & Johnson and 2 Other AI Stocks Are Beating the Market by 29 Points.

Johnson & Johnson (NYSE:JNJ) Has A Better Balance Sheet Than The Government, Said Jim Cramer

J&J's China Pill Win Challenges Its Own Injection Franchise

Best Healthcare Stocks To Follow Now - August 28th - Daily Political

Kelleher Financial Advisors Has $3.19 Million Stake in Johnson & Johnson $JNJ - Markets Daily

Kelleher Financial Advisors Buys 2,254 Shares of Johnson & Johnson $JNJ - Zolmax

Private Advisory Group LLC Acquires 41,632 Shares of Johnson & Johnson $JNJ

Russell Investments Group Ltd. Cuts Stock Holdings in Johnson & Johnson $JNJ

SCS Capital Management LLC Has $26.73 Million Stake in Johnson & Johnson $JNJ

Private Advisory Group LLC Purchases 41,632 Shares of Johnson & Johnson $JNJ - Stock Observer

Johnson & Johnson's Psoriasis Pill Approved in China: A Game Changer in Skin Treatment, ETPharma

CORDA Investment Management LLC. Sells 3,626 Shares of Johnson & Johnson $JNJ - Daily Political

Johnson & Johnson (JNJ)'s Imaavy Expands Into Rare Blood Disorder: What Investors Should Know

New FDA Approval Gives Bristol-Myers Squibb (BMY) Another Potential Oncology Growth Catalyst

Johnson & Johnson (NYSE:JNJ) Stock Price Down 1.4% - Here's What Happened

I Think Johnson & Johnson Is the Best Dividend Stock to Buy Right Now

Top Pharmaceutical Stocks To Research - August 27th - Zolmax

Top Healthcare Stocks To Watch Now - August 27th - Stock Observer

J&J's latest Impella recall tied to 3 deaths, 37 injuries

Mitsubishi UFJ Trust & Banking Corp Has $427.78 Million Stock Position in Johnson & Johnson $JNJ - Markets Daily

Johnson & Johnson $JNJ Shares Purchased by Mitsubishi UFJ Trust & Banking Corp

Mosaic Family Wealth Partners LLC Grows Stake in Johnson & Johnson $JNJ

Kinsale Capital Group Inc. Raises Stake in Johnson & Johnson $JNJ

Johnson & Johnson Just Got a Big FDA Win

Meridian Wealth Management LLC Has $13.60 Million Stake in Johnson & Johnson $JNJ - Stock Observer

Ageing, Innovation and AI: 10 Healthcare Stocks Positioned to Benefit | Financial Horse

CD19 CAR T cell therapy for treatment-refractory seropositive rheumatoid arthritis: a phase 1 trial

Top Analyst Reports for JPMorgan, Johnson & Johnson & Mastercard

How Much Upside Is Left in JNJ Stock?

Top Healthcare Stocks To Keep An Eye On - August 26th - Markets Daily

Dividends vs. an Annuity: Which Turns $840,000 Into More Monthly Income for Life?

Atrial Fibrillation Treatment Devices Market Trends and Forecast, 2035 | Includes Profiles of Abbott, AtriCure, Boston Scientific, Johnson & Johnson, and Medtronic

HighTower Advisors LLC Sells 591,434 Shares of Johnson & Johnson $JNJ - Markets Daily

Janney Montgomery Scott LLC Reduces Stock Holdings in Johnson & Johnson $JNJ

Parr Mcknight Wealth Management Group LLC Purchases 5,142 Shares of Johnson & Johnson $JNJ - Stock Observer

GWN Securities Inc. Trims Stock Position in Johnson & Johnson $JNJ - Daily Political

Fifth Third Bancorp Cuts Stake in Johnson & Johnson $JNJ - Daily Political

Johnson & Johnson (JNJ) Stock: Surge as FDA Approval and European Cancer Treatment Expansion Drive Market Attention

Johnson & Johnson Is Near a Record High. Is There Still Room to Run?

"Give Me Anything But Tech": Jim Cramer's Bold Call on the Market's Next Big Rotation

Promising Pharmaceutical Stocks To Follow Now - August 25th - Daily Political

Strategic Wealth Investment Group LLC Reduces Holdings in Johnson & Johnson $JNJ

Johnson & Johnson $JNJ Shares Acquired by Principal Financial Group Inc.

GraniteShares Advisors LLC Makes New Investment in Johnson & Johnson $JNJ

Golden Reserve Retirement LLC Has $1.72 Million Position in Johnson & Johnson $JNJ

FDA Approves J&J's IMAAVY For Warm Autoimmune Hemolytic Anemia

Strategic Wealth Investment Group LLC Sells 10,326 Shares of Johnson & Johnson $JNJ - Daily Political

Does Louisiana's US$10 Million Talc Verdict Shift the Legal Risk Bull Case For Johnson & Johnson (JNJ)?

FDA approves IMAAVY® (nipocalimab-aahu) as first-ever treatment for warm autoimmune hemolytic anemia (wAIHA), representing a landmark advancement for patients | Morningstar

Q2 Earnings Season Winds Down: 3 Companies That Broke Records

J&J's Strong Pipeline Momentum Offers Multiple Growth Catalysts Ahead

Johnson & Johnson's multiple myeloma treatment secures EC approval

TD Asset Management Inc Grows Stock Holdings in Johnson & Johnson $JNJ

Willis Investment Counsel Raises Stock Holdings in Johnson & Johnson $JNJ - Stock Observer

Pfizer vs. Johnson & Johnson: Which Pharma Giant Is Better Prepared for Its Patent Cliff?

Towards precision psychiatry: initial foundations and future directions

Is Johnson & Johnson's $5.5 Billion Talc Settlement a Buy Signal, or Is the Legal Risk Far From Over?

Johnson & Johnson vs. Thermo Fisher: Which Healthcare Growth Story Is More Durable?

Better Dividend King to Buy Right Now: Abbott Labs or Johnson & Johnson?

This Company Has Raised Its Dividend for 72 Straight Years. Almost Nobody Talks About It.

How to Build $6,600 a Month in Dividend Income From Three Income Buckets

Johnson & Johnson (JNJ) Wins EU Approval For TECVAYLI Combo In Multiple Myeloma

2 Dividend Stocks to Buy and Never Sell

Johnson & Johnson $JNJ Stock Position Boosted by Osprey Private Wealth LLC

Johnson & Johnson $JNJ is Pinnacle Associates Ltd.'s Largest Position

BIP Wealth LLC Has $3.98 Million Position in Johnson & Johnson $JNJ

Johnson & Johnson $JNJ Shares Purchased by Stack Financial Management Inc - Stock Observer

Johnson & Johnson $JNJ Position Reduced by Oppenheimer Asset Management Inc. - Daily Political

Top Pharmaceutical Stocks To Research - August 20th - Daily Political

How a 53-Year-Old Can Turn $465,000 Into a Monthly Paycheck Machine by 63

If a Stock Market Crash Is Coming, History Says Buying and Holding These Stocks Is a Smart Move

4,247 Shares in Johnson & Johnson $JNJ Bought by Xcel Wealth Management LLC

3 Dividend Stocks to Buy and Hold for the Next 5 Years

Johnson & Johnson (NYSE:JNJ) Shares Up 1.2% - Here's Why

Sector Update: Healthcare Stocks Advance in Afternoon Trading

Johnson & Johnson (NYSE:JNJ) Stock Price Up 1.2% - Here's Why - Daily Political

Johnson & Johnson's TECVAYLI-Daratumumab Combo Wins EU Approval For Relapsed Myeloma

D.A. Davidson & CO. Sells 47,658 Shares of Johnson & Johnson $JNJ - Markets Daily

Johnson & Johnson $JNJ Stake Cut by D.A. Davidson & CO.

Who is Manish Anandani, Colgate-Palmolive India's incoming MD & CEO?

Johnson & Johnson $JNJ Stock Position Raised by Bogart Wealth LLC - Markets Daily

Brookmont Capital Management Increases Stock Position in Johnson & Johnson $JNJ

Colgate Palmolive India appoints Kenvue exec as MD and CEO

Trinity Legacy Partners LLC Sells 4,917 Shares of Johnson & Johnson $JNJ - Stock Observer

GSA Capital Partners LLP Purchases New Holdings in Xencor, Inc. $XNCR - Daily Political

Johnson & Johnson (NYSE:JNJ) Trading Down 2% - Should You Sell?

CrowdStrike Stock Forecast 2026–2030: Can Record Net New ARR Extend CRWD’s 20% Earnings Rally?

Polkadot DOT Price Prediction 2026, 2027 & 2030: Can DOT Recover Above $5?

All Eyes on Fed Chair Warsh: FOMC Outlook

NVDA Stock Forecast: Is $300 Within Reach After Record Q2 Earnings?

XRP Price Forecast 2026, 2027-2030: Can Record Cumulative ETF Inflows Push XRP Back Above $1.70?

Gold Price Trend 2024-2026: From $2,000 to Record Highs, What Comes Next?

Upcoming IPOs 2026: The Biggest Companies to Watch and Major Listings So Far

10 Best Brokers to Trade Indices in 2026

7 Best S&P 500 Index Funds and ETFs for 2026

8 Best Forex Brokers in Dubai for 2026: Compare Platforms, Leverage and Swap-Free Accounts

Silver Price Today, August 28: XAG/USD Reclaims $70 Ahead of Fed Speech

Apple Stock Rises 0.36% Ahead of September 9 ‘Surprise and Shine’ Event

Gold Price Today, August 28: XAU/USD Slips Toward $4,580 Ahead of Fed Speech

Oil Prices Extend Losses as Hormuz Reopening Hopes Ease Supply Concerns

Solana Price Jumps 9% Above $110 as Tokenomics Vote Reaches Quorum

Nvidia Breaks Its Earnings-Day Curse With 8.7% Surge and $442 Billion Market-Cap Gain

Marvell Stock Falls 6% Despite Q2 Earnings Beat

NVIDIA Shares Surge 8.74% as Q2 Revenue Doubles and FY2028 Outlook Revives AI Rally